We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
+15.15%
1 Year Est. Return
+37.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$490M
AUM Growth
+$313M
Cap. Flow
+$275M
Cap. Flow %
56.08%
Top 10 Hldgs %
58.34%
Holding
57
New
36
Increased
7
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$39.3M
2
BRO icon
Brown & Brown
BRO
+$25.3M
3
EW icon
Edwards Lifesciences
EW
+$19.2M
4
QXO
QXO Inc
QXO
+$19.1M
5
BIRK icon
Birkenstock
BIRK
+$18.9M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$40.2M
2
ETR icon
Entergy
ETR
+$17.1M
3
AEP icon
American Electric Power
AEP
+$16.4M
4
ADT icon
ADT
ADT
+$9.97M
5
KKR.PRD
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
+$5.52M

Sector Composition

Rank Sector Weight
1 Healthcare 26.24%
2 Financials 18.92%
3 Consumer Discretionary 14.37%
4 Industrials 11.18%
5 Technology 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
CALL
Humana
HUM
$46.7B
$73.3M 14.97%
+300,000
New +$74.8M
CAI
2
Caris Life Sciences
CAI
$4.39B
$39M 7.96%
+1,459,745
New +$39.3M
QXO
3
QXO Inc
QXO
$14.2B
$25M 5.11%
+1,162,406
New +$19.1M
BRO icon
4
Brown & Brown
BRO
$22.9B
$24.9M 5.09%
+225,000
New +$25.3M
SARO
5
StandardAero Inc
SARO
$9.54B
$24.5M 5%
773,750
+198,750
+35% +$5.57M
AS icon
6
Amer Sports
AS
$19.7B
$20.9M 4.27%
+540,000
New +$16.6M
TPG icon
7
TPG
TPG
$6.87B
$20.7M 4.22%
+394,273
New +$18.9M
EW icon
8
Edwards Lifesciences
EW
$47.6B
$20.1M 4.11%
+257,350
New +$19.2M
BTSG icon
9
BrightSpring Health Services
BTSG
$14.3B
$19.1M 3.89%
808,052
+708,079
+708% +$14.8M
BIRK icon
10
Birkenstock
BIRK
$7.47B
$18.1M 3.7%
+368,590
New +$18.9M
VIK icon
11
Viking Holdings
VIK
$44.9B
$17.9M 3.66%
336,233
+32,510
+11% +$1.44M
HOLX
12
DELISTED
Hologic
HOLX
$17.3M 3.53%
+265,000
New +$15.9M
GLXY
13
Galaxy Digital Inc
GLXY
$4.34B
$15.3M 3.13%
+700,000
New +$14.2M
WAY
14
Waystar Holding Corp
WAY
$4.32B
$14.8M 3.03%
363,091
+48,791
+16% +$1.88M
SAIL
15
SailPoint Inc
SAIL
$8.48B
$10.7M 2.18%
466,357
+115,992
+33% +$2.19M
HUM icon
16
Humana
HUM
$46.7B
$10.2M 2.09%
+41,830
New +$10.4M
KVYO icon
17
Klaviyo
KVYO
$4.91B
$10.1M 2.07%
+301,503
New +$9.55M
NDAQ icon
18
Nasdaq
NDAQ
$51.5B
$8.94M 1.82%
+99,961
New +$7.98M
AHL
19
DELISTED
Aspen Insurance
AHL
$8.45M 1.72%
+268,440
New +$8.95M
KKR.PRD
20
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.21B
$8.04M 1.64%
150,000
-112,500
-43% -$5.52M
SFD
21
Smithfield Foods
SFD
$10.3B
$7.38M 1.51%
313,482
-107,433
-26% -$2.37M
SCHW
22
Charles Schwab
SCHW
$177B
$7.18M 1.47%
78,666
-480,634
-86% -$40.2M
RACE icon
23
Ferrari
RACE
$63.3B
$7M 1.43%
14,266
+6,732
+89% +$3.13M
SNDK
24
Sandisk
SNDK
$213B
$6.8M 1.39%
+150,000
New +$5.74M
TTAN
25
ServiceTitan Inc
TTAN
$6.72B
$6.7M 1.37%
+62,500
New +$6.99M
1
2 3

Similar funds

GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $2.7B AUM 23.82% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return

Longaeva Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Longaeva Partners held 57 positions worth $490M, up 177% from $177M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Longaeva Partners deployed $275M of net new capital in Q2 2025, opening 36 new positions and adding to 7 existing holdings. Its largest new stake was Caris Life Sciences: 1,459,745 shares worth $39M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Charles Schwab, an estimated $40.2M trimmed.

  • Longaeva Partners's largest Q2 2025 buy was Caris Life Sciences: 1,459,745 shares worth $39M.
  • Longaeva Partners added most to BrightSpring Health Services in Q2 2025, an estimated $14.8M increase.
  • Longaeva Partners's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $40.2M.
  • Longaeva Partners fully exited Entergy in Q2 2025, selling an estimated $17.1M.
  • Longaeva Partners's ten largest holdings make up 58% of its $490M portfolio in Q2 2025.
  • Longaeva Partners opened 36 new positions and closed 3 in Q2 2025.
  • Longaeva Partners's portfolio value rose 177% quarter-over-quarter to $490M.

Based on Longaeva Partners's 13F filing for Q2 2025, filed 14 Aug 2025.